VistaGen Therapeutics Inc
VTGN
$0.24+2.74%
End of day · as of Sep 19, 2026, 6:15 PM ET
Mkt cap
$28.12M
EV/Sales
-2.11
P/E ratio
N/A
FY2026 Revenue
$1.27M
EPS (9mo ended 2025-12-31)
$-1.46
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
-5491.33%
Beta
N/A
Div yield
N/A
Sector
Healthcare
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 19.3% from 2024-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
Use this VTGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VTGN income, balance, and cash tables.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company in the Healthcare sector.
Latest cached VistaGen Therapeutics Inc (VTGN) revenue for Mar 31, 2026 was $1.3M. Net income was -$69.7M. Statements: https://lician.com/financials/vtgn
VistaGen Therapeutics Inc (VTGN) market capitalization is $28.1M on the latest cached snapshot.
VistaGen Therapeutics Inc (VTGN) cached previous close $0.23; day range $0.23 – $0.25; volume 716,972. Session quote: https://lician.com/quote/vtgn
VistaGen Therapeutics Inc (VTGN) latest cached earnings event is "VTGN earnings" on Aug 20, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VTGN filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/vtgn